Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.0900
-0.0050 (-5.26%)
Jun 30, 2026, 2:40 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 30.95 million as of July 1, 2026. Its market cap has increased by 172.16% in one year.
Market Cap
30.95M
Enterprise Value
154.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 30.95M, an increase of 34.90%. That is a compound annual growth rate of 1.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 30.95M | 7.62% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 51.55M |
| MedMira | 49.12M |
| Microbix Biosystems | 40.64M |
| Defence Therapeutics | 37.89M |
| BriaCell Therapeutics | 37.84M |
| Medicenna Therapeutics | 37.38M |
| Quantum BioPharma | 34.30M |
| Sharp Therapeutics | 30.08M |